Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury.
Deng C, Zhao L, Yang Z, Shang JJ, Wang CY, Shen MZ, Jiang S, Li T, Di WC, Chen Y, Li H, Cheng YD, Yang Y.
Deng C, et al. Among authors: chen y.
Acta Pharmacol Sin. 2022 Mar;43(3):520-528. doi: 10.1038/s41401-021-00676-7. Epub 2021 May 26.
Acta Pharmacol Sin. 2022.
PMID: 34040166
Free PMC article.
Review.